Sam Altman is reportedly entering in brain-computer interface domain through a new startup, Merge Labs. The company is ...

Merge Labs will compete with Elon Musk’s Neuralink, which is developing computer interface chips designed to be implanted in ...

Sam Altman is planning a brain implant startup to rival Elon Musk’s Neuralink: OpenAI is planning to invest in a brain ...

OpenAI is reportedly discussing a potential investment in a new startup that aims to compete with Elon Musk’s brain implant ...

Microsoft (NASDAQ:MSFT)-backed OpenAI co-founder Sam Altman is gearing up to back Merge Labs, a new brain-computer interface startup that could go head-to-head with Elon Musk's Neuralink, the ...

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting ...

Merge Labs is a new Neuralink rival developing brain-computer interfaces. If you’ve enjoyed Elon Musk’s ongoing beef with ...

Merge Labs venture comes after OpenAI boss Sam Altman said the race to embed AI in humans is ‘going to get a lot weirder’ ...

The Financial Times reports today that OpenAI co-founder Sam Altman plans to invest in new brain-computer interface (BCI) venture Merge Labs.

The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify ...

The rivalry between Sam Altman, CEO of OpenAI, and Tesla’s Elon Musk has taken on a new dimension as Altman is named a ...